Treatment of Chronic Anemia With Epoetin Alfa in Elderly

Status unconfirmed · Phase 2

Conditions studied: Anemia

In brief

The purpose of this study is to determine if chronic anemia can be corrected with epoetin alfa and does the subsequent correction lead to an improvement in fatigue,quality of life or mobility among elderly.

Key facts

Study ID

NCT00337441

Run by

Research and Education Foundation of Michael Reese Hospital

People needed

62

Starts

2003-01-01

Expected to finish

2005-07-01

Last updated by the study team

2006-06-16

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 65 years of age or older Diagnosed with chronic anemia Hemoglobin level less than or equal to 11.5 g/dl Community dwelling Able to make monthly clinic visits

You may not qualify if…

• Currently on Epoetin alfa or similar preparations Having nutritional anemia Having active cancer or received recent treatment for cancer On treatment for Kidney disease Diagnosis of dementia Inability to ambulate

Where it is running

• John H. Stroger Jr. Hospital of Cook County — Chicago, Illinois, United States
• Mercy Hospital and Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.